Name | Number of supported studies | Average coverage | |
---|---|---|---|
ciliated cell | 10 studies | 25% ± 9% | |
glutamatergic neuron | 10 studies | 42% ± 27% | |
epithelial cell | 7 studies | 28% ± 18% | |
adipocyte | 7 studies | 25% ± 8% | |
GABAergic neuron | 6 studies | 42% ± 22% | |
interneuron | 5 studies | 33% ± 12% | |
hepatocyte | 4 studies | 40% ± 20% | |
neuron | 3 studies | 23% ± 3% | |
GABAergic interneuron | 3 studies | 23% ± 8% | |
granule cell | 3 studies | 22% ± 5% | |
oligodendrocyte precursor cell | 3 studies | 21% ± 3% | |
enteroendocrine cell | 3 studies | 19% ± 3% | |
goblet cell | 3 studies | 31% ± 19% |
Name | Number of supported studies | Average coverage | |
---|---|---|---|
brain | 7 studies | 37% ± 22% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
pancreas | 100% | 16413.73 | 328 / 328 | 91% | 14.19 | 162 / 178 |
adrenal gland | 97% | 1928.09 | 250 / 258 | 93% | 17.67 | 213 / 230 |
breast | 97% | 2943.29 | 447 / 459 | 92% | 14.45 | 1023 / 1118 |
liver | 100% | 4445.72 | 226 / 226 | 88% | 16.15 | 358 / 406 |
thymus | 100% | 5041.95 | 652 / 653 | 87% | 28.52 | 529 / 605 |
prostate | 83% | 1097.44 | 204 / 245 | 100% | 31.25 | 500 / 502 |
ovary | 93% | 2434.46 | 168 / 180 | 79% | 7.88 | 340 / 430 |
stomach | 77% | 2737.81 | 276 / 359 | 95% | 29.81 | 273 / 286 |
lung | 63% | 741.17 | 365 / 578 | 91% | 12.63 | 1049 / 1155 |
intestine | 53% | 3274.32 | 510 / 966 | 97% | 35.29 | 513 / 527 |
brain | 80% | 2045.85 | 2115 / 2642 | 38% | 3.57 | 269 / 705 |
bladder | 29% | 228.86 | 6 / 21 | 79% | 15.62 | 397 / 504 |
ureter | 0% | 0 | 0 / 0 | 100% | 4.32 | 1 / 1 |
esophagus | 4% | 35.76 | 62 / 1445 | 89% | 16.92 | 162 / 183 |
adipose | 90% | 3122.07 | 1088 / 1204 | 0% | 0 | 0 / 0 |
heart | 76% | 1331.21 | 653 / 861 | 0% | 0 | 0 / 0 |
kidney | 63% | 577.75 | 56 / 89 | 13% | 1.65 | 116 / 901 |
skin | 72% | 2170.04 | 1306 / 1809 | 3% | 0.19 | 12 / 472 |
tonsil | 0% | 0 | 0 / 0 | 71% | 6.25 | 32 / 45 |
uterus | 3% | 25.75 | 5 / 170 | 62% | 7.42 | 285 / 459 |
muscle | 51% | 917.00 | 411 / 803 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 17% | 2.27 | 5 / 29 |
blood vessel | 5% | 66.93 | 73 / 1335 | 0% | 0 | 0 / 0 |
peripheral blood | 2% | 14.00 | 16 / 929 | 0% | 0 | 0 / 0 |
spleen | 0% | 2.81 | 1 / 241 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 80 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0010628 | Biological process | positive regulation of gene expression |
GO_0031032 | Biological process | actomyosin structure organization |
GO_0045785 | Biological process | positive regulation of cell adhesion |
GO_0010837 | Biological process | regulation of keratinocyte proliferation |
GO_0051549 | Biological process | positive regulation of keratinocyte migration |
GO_0042060 | Biological process | wound healing |
GO_0005856 | Cellular component | cytoskeleton |
GO_0005829 | Cellular component | cytosol |
GO_0045177 | Cellular component | apical part of cell |
GO_0005886 | Cellular component | plasma membrane |
GO_0005737 | Cellular component | cytoplasm |
GO_0005923 | Cellular component | bicellular tight junction |
GO_0005200 | Molecular function | structural constituent of cytoskeleton |
GO_0008092 | Molecular function | cytoskeletal protein binding |
Gene name | EPB41L4B |
Protein name | Erythrocyte membrane protein band 4.1 like 4B, isoform CRA_a (cDNA: FLJ21596 fis, clone COL07110) Erythrocyte membrane protein band 4.1 like 4B, isoform CRA_b (cDNA FLJ20381 fis, clone KAIA2329) Band 4.1-like protein 4B (Erythrocyte membrane protein band 4.1-like 4B) (FERM-containing protein CG1) (Protein EHM2) |
Synonyms | hCG_1738334 EHM2 LULU2 |
Description | FUNCTION: Up-regulates the activity of the Rho guanine nucleotide exchange factor ARHGEF18 (By similarity). Involved in the regulation of the circumferential actomyosin belt in epithelial cells . Promotes cellular adhesion, migration and motility in vitro and may play a role in wound healing . May have a role in mediating cytoskeletal changes associated with steroid-induced cell differentiation . . |
Accessions | Q9H329 Q9NX84 ENST00000374557.4 [Q9H329-2] Q9H709 ENST00000374566.8 [Q9H329-1] |